Answers are grounded in this paper and cite their sources.
Background Pseudoexfoliation syndrome (PEX) is a major identifiable cause of secondary glaucoma, but nationwide data from Latin America remain limited. Methods We conducted a nationwide, multicenter, cross-sectional, ophthalmology-based study from July 1, 2024, to June 30, 2025. Participating ophthalmologists reported all patients aged 40 years or older examined during routine care and recorded standardized clinical data for patients in whom PEX was identified. PEX was defined by at least one prespecified slit-lamp or gonioscopic sign. The primary outcome was the observed prevalence of PEX among examined patients. Ocular findings, glaucoma status, geographic distribution, and reported systemic comorbidities were described among PEX cases. Results Among 98,933 patients examined at 199 ophthalmology centers, 2,848 had PEX, corresponding to an observed prevalence of 2.88%. A post hoc sensitivity analysis requiring definite exfoliative material at the pupillary margin and/or anterior lens capsule in at least one eye identified 2,844 cases, yielding an essentially unchanged observed prevalence of 2.87%. Among affected patients, 1,303 (45.8%) had unilateral and 1,545 (54.2%) bilateral PEX, corresponding to 4,393 affected eyes. The mean age of patients with PEX was 75.0 years (standard deviation, 8.6), and 59.0% were female. PEX material was most frequently observed at the pupillary margin. Any clinician-diagnosed glaucoma was recorded in 58.4% of affected patients; glaucoma subtype was not systematically recorded. The most frequently reported systemic comorbidities were arterial hypertension (52.1%), hearing loss (22.3%), and diabetes (17.2%). Conclusion PEX was identified in nearly 3% of patients aged 40 years or older attending participating ophthalmology centers across Argentina, and more than half of affected patients had coexisting clinician-diagnosed glaucoma. Reported systemic comorbidities characterize the clinical profile of patients with PEX but do not establish comparative or causal associations. These findings provide a national clinical benchmark for PEX detection and a foundation for future population-based and longitudinal research.
No takes yet. Share an insight, caveat, or question.
Logioco et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: